4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics

4BIO Capital to Use Insig AI’s Technology to Accelerate the Discovery of Innovative Investments

4BIO Capital Announces Strategic Partnership with Harbor Capital Advisors

SparingVision announces strategic collaboration with Intellia Therapeutics

4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics

SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT Therapeutics